MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

The potential role of Per- and Polyfluoroalkyl Substances (PFAS) in movement disorders: Implications and Risk assessment to Human Health

N. Verma (Barotiwala, India)

Meeting: 2022 International Congress

Abstract Number: 24

Keywords: Environmental toxins, Evoked potentials, Neurobehavioral disorders

Category: Allied Healthcare Professionals

Objective: The objective of our study is to critically summarized the neurotoxicity of Perfluoroalkyl substances (PFAS) and linked this environmental pollutant with movement disorders and developmental neurotoxicity.

Background: Perfluoroalkyl substances (PFAS) are a type of chemical that was widely employed in manufacturing and is now found in the environment all over the world. Although many PFAS are detectable in human blood serum, the potential for adverse health effects is unknown. Many investigations have been done so far to assess and investigate PFAS and related substances toxicity and better understand the connections between environmental pollutants and its implication on human health. In this presentation we will highlights critical assessment of various investigations reported and PFAS neurotoxicity. PFAS has also been associated and linked linked to developmental neurotoxicity

Method: Systematic review of literatures

Results: Many investigations have been done so far to assess and investigate PFAS and related substances toxicity and better understand the connections between environmental pollutants and its implication on human health.

Conclusion: critical assessment of various investigations reported   and PFAS neurotoxicity. PFAS has also been associated and linked to developmental neurotoxicity.

To cite this abstract in AMA style:

N. Verma. The potential role of Per- and Polyfluoroalkyl Substances (PFAS) in movement disorders: Implications and Risk assessment to Human Health [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/the-potential-role-of-per-and-polyfluoroalkyl-substances-pfas-in-movement-disorders-implications-and-risk-assessment-to-human-health/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/the-potential-role-of-per-and-polyfluoroalkyl-substances-pfas-in-movement-disorders-implications-and-risk-assessment-to-human-health/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley